Literature DB >> 17189819

Intraoperative floppy-iris syndrome, alpha1-adrenergic antagonists, and chronic intake of mianserin: is there an association?

Marta Ugarte, Tony Leong, Salwan Rassam, Chee H Kon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17189819     DOI: 10.1016/j.jcrs.2006.07.047

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


× No keyword cloud information.
  7 in total

1.  Correlation between urological alpha1-AR antagonist medication and changed intraoperative iris behavior.

Authors:  Karin Horvath; Florina Vultur
Journal:  Int Ophthalmol       Date:  2011-01-29       Impact factor: 2.031

2.  Risk factors for intraoperative floppy iris syndrome: a prospective study.

Authors:  I P Chatziralli; V Peponis; E Parikakis; A Maniatea; E Patsea; P Mitropoulos
Journal:  Eye (Lond)       Date:  2016-07-01       Impact factor: 3.775

3.  Urologic medications and ophthalmologic side effects: a review.

Authors:  Johan Gani; Nathan Perlis; Sidney B Radomski
Journal:  Can Urol Assoc J       Date:  2012-02       Impact factor: 1.862

4.  Intraoperative floppy iris syndrome and its association with various concurrent medications, bulbus length, patient age and gender.

Authors:  Michael Wahl; Saskia M Tipotsch-Maca; Pia V Vecsei-Marlovits
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-10-19       Impact factor: 3.117

5.  Alpha-blockers and intraoperative floppy iris syndrome: ophthalmic adverse events following cataract surgery.

Authors:  Zuhair K Al-Hussaini; Kevin T McVary
Journal:  Curr Urol Rep       Date:  2010-07       Impact factor: 3.092

6.  Floppy iris syndrome with oral imipramine: a case series.

Authors:  Arvind Gupta; Renuka Srinivasan
Journal:  Indian J Ophthalmol       Date:  2012 Mar-Apr       Impact factor: 1.848

7.  Intraoperative floppy iris syndrome in Indian population: a prospective study on incidence, risk factors, and impact on operative performance.

Authors:  Shilpa Goyal; Deepansh Dalela; Neeraj Kumar Goyal; Shobhit Chawla; Rajat Dhesi; Bela Kamboj; Abha Dalela
Journal:  Indian J Ophthalmol       Date:  2014-08       Impact factor: 1.848

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.